Browse > Article

Qualitative Analysis for Metabolites of Pharmaceuticals Formed in Daphnia magna and Gammarus pulex Using Liquid Chromatogram-High Resolution Mass Spectrometry (LC-HRMS)  

Jeon, Junho (Department of Environmental Engineering, Changwon National University)
Publication Information
Journal of Environmental Analysis, Health and Toxicology / v.21, no.4, 2018 , pp. 243-251 More about this Journal
Abstract
Pharmaceuticals in wastewater effluents have been recognized as emerging pollutants threatening freshwater organisms. To extend understanding for bioaccumulation and toxicity in those organisms, information on biotransformation products (or metabolites) and their metabolic pathway are crucial. The aim of the present study is to identify and elucidate metabolites of pharmaceuticals formed in exposed organisms using suspect and nontarget screening approach using LC-HRMS. As the target pharmaceuticals, carbamazepine, ketoprofen, metoprolol, propranolol, and verapamil were selected whereas Daphnia magna and Gammarus pulex were used as test organisms. After 24h exposure, metabolites formed in the organisms were identified using LC-HRMS. The structures of metabolites were elucidated via analysis of MS/MS fragment pattern and the comparison with fragment database. As the results, a total of 10 metabolites were identified for 5 parent compounds (C253/C356 for carbamazepine, K211 for ketoprofen, M256 for metoprolol, P218/P276/P306 for propranolol, V196/V291/V441 for verapamil). Among them, the presence of C253 and V291 was confirmed using standard materials. Most of the identified metabolites were formed through oxidative reactions such as hydroxylation, N-demethylation, and dealkylation. Cysteine conjugation (phase II reaction) metabolite (C356) for carbamazepine was found in daphnia. The metabolic pathway of verapamil showed similar metabolic pathways and metabolic pathways for both species. Although the toxicological information on the identified metabolites could not be confirmed, the molecular structure information of the proposed metabolites can be used for future evaluation and prediction of toxicity.
Keywords
Pharmaceuticals; Metabolite; Structure elucidation; LC-HRMS; Suspect and nontarget screening;
Citations & Related Records
연도 인용수 순위
  • Reference
1 A. Bahlmann, W. Brack, R. J. Schneider, and M. Krauss, “Carbamazepine and its metabolites in wastewater: Analytical pitfalls and occurrence in Germany and Portugal”, Water Research, 2014, 57, 104-114.   DOI
2 M. Gu, Y. Wang, X. G. Zhao, and Z. M. Gu, “Accurate mass filtering of ion chromatograms for metabolite identification using a unit mass resolution liquid chromatography/mass spectrometry system”, Rapid Communications in Mass Spectrometry, 2006, 20, 764-770.   DOI
3 P. Partani, Y. Modhave, S. Gurule, A. Khuroo, and T. Monif, “Simultaneous determination of propranolol and 4-hydroxy propranolol in human plasma by solid phase extraction and liquid chromatography/electrospray tandem mass spectrometry”, Journal of Pharmaceutical and Biomedical Analysis, 2009, 50, 966-976.   DOI
4 E. Tudela, K. Deventer, L. Geldof, and P. Van Eenoo, “Urinary detection of conjugated and unconjugated anabolic steroids by dilute-and-shoot liquid chromatography-high resolution mass spectrometry”, Drug Testing and Analysis, 2015, 7, 95-108.   DOI
5 J. Jeon, D. Kurth, R. Ashauer, and J. Hollender, "Comparative toxicokinetics of organic micropollutants in freshwater crustaceans", Environmental Science and Technology, 2013, 47.
6 W. Alderton, S. Berghmans, P. Butler, H. Chassaing, A. Fleming, Z. Golder, F. Richards, and I. Gardner, "Accumulation and metabolism of drugs and CYP probe substrates in zebrafish larvae", Xenobiotica, 2010.
7 A. A. Bletsou, J. Jeon, J. Hollender, E. Archontaki, and N. S. Thomaidis, “Targeted and non-targeted liquid chromatography-mass spectrometric workflows for identification of transformation products of emerging pollutants in the aquatic environment”, Trends in Analytical Chemistry, 2015, 66, 32-44.   DOI
8 H. P. Singer, A. E. Wossner, C. S. McArdell, and K. Fenner, "Rapid screening for exposure to 'non-Target' pharmaceuticals from wastewater effluents by combining HRMS-Based suspect screening and exposure modeling", Environmental Science and Technology, 2016, 50, 6698-6707.   DOI
9 Y. Yoon, J. Ryu, J. Oh, B. G. Choi, and S. A. Snyder, "Occurrence of endocrine disrupting compounds, pharmaceuticals, and personal care products in the Han River (Seoul, South Korea)", Science of the Total Environment, 2010, 408, 636-643.   DOI
10 J. Jeon, D. Kurth, and J. Hollender, “Biotransformation pathways of biocides and pharmaceuticals in freshwater crustaceans based on structure elucidation of metabolites using high resolution mass spectrometry”, Chemical Research in Toxicology, 2013, 26, 313-324.   DOI
11 A. Rosch, S. Anliker, and J. Hollender, “How biotransformation influences toxicokinetics of azole fungicides in the aquatic invertebrate Gammarus pulex”, Environmental Science and Technology, 2016, 50, 7175-7188.   DOI
12 T. Kind, and O. Fiehn, “Seven Golden Rules for heuristic filtering of molecular formulas obtained by accurate mass spectrometry”, BMC Bioinformatics, 2007, 8, 105.   DOI
13 A. Kretschmann, R. Ashauer, K. Hitzfeld, P. Spaak, J. Hollender, and B. I. Escher, "Mechanistic toxicodynamic model for receptor-mediated toxicity of diazoxon, the active metabolite of diazinon, in Daphnia magna", Environmental Science and Technology, 2011, 45, 4980-4987.   DOI
14 E. L. Schymanski, J. Jeon, R. Gulde, K. Fenner, M. Ruff, H. P. Singer, and J. Hollender, “Identifying small molecules via high resolution mass spectrometry: Communicating confidence”, Environmental Science and Technology, 2014, 48, 2097-2098.   DOI
15 OECD, "OECD 202 - Daphnia sp., Acute Immobilisation Test and Reproduction Test", 2004.